A Study of the Efficacy and Safety of ETC-1002 in Subjects With Statin Intolerance
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
This study will assess the LDL-C lowering efficacy and safety of ETC-1002 versus placebo in
subjects with hypercholesterolemia and a history of statin intolerance.